Industry ยท Oct 2026
Specialty Insurance stocks ranked by gap to the model's fair value
Faircurve's model values 9 specialty insurance stocks. 0 of them are ranked below by the gap between the model's fair value and the last close, as of 31 Oct 2026: 0 read as Undervalued, 0 as Fairly valued and 0 as Overvalued.
Valuations as of . Prices are the closes of 3 Nov 2026. The gap is the model's fair value against the price: a positive gap means the fair value is above the price. It states what the model concluded, not where the price goes next.
The ranking
No specialty insurance stock meets the conditions for a rank today.
The Global Pulse
Faircurve's market note, in your inbox each market day
The Global Pulse is Faircurve's note after each US session: what moved, in plain words. No account needed.
Valued but not ranked
These 9 names are valued but not ranked, for one of five reasons: the model grades the evidence as low or has not graded it yet, the inputs are under review, the gap is wider than 60%, the valuation is more than three weeks old, or the name is a bank, an insurer or a REIT, which this list does not rank yet. The numbers are shown for reference.
| Company | Last close | Model fair value | Gap | Why it is not ranked | Quality score | Market value |
|---|---|---|---|---|---|---|
| ACT Enact Holdings Inc. | $47.50 | $50.47 | +6.3% | Low evidence grade | $6.5B | |
| AGO Assured Guaranty Ltd. | $71.29 | $66.24 | -7.1% | Low evidence grade | $3.1B | |
| EIG Employers Holdings, Inc. | $47.35 | $22.85 | -51.7% | Banks, insurers and REITs are not ranked yet | $804M | |
| ESNT Essent Group Ltd. | $67.71 | $82.42 | +21.7% | Low evidence grade | $6.0B | |
| FAF First American Financial Corporation | $64.97 | $62.41 | -3.9% | Banks, insurers and REITs are not ranked yet | $6.5B | |
| FNF Fidelity National Financial, Inc. | $41.39 | $54.85 | +32.5% | Low evidence grade | $10.9B | |
| MTG MGIC Investment Corporation | $28.64 | $35.38 | +23.5% | Low evidence grade | $5.8B | |
| NMIH NMI Holdings, Inc. | $43.31 | $55.61 | +28.4% | Low evidence grade | $3.2B | |
| RDN Radian Group Inc. | $35.84 | $47.84 | +33.5% | Low evidence grade | $4.7B |